Scientists at the Lewis Katz School of Medicine at Temple University (LKSOM) have successfully edited SIV – a virus closely related to HIV – from the genomes of non-human primates. The breakthrough brings Temple researchers and their collaborators closer to developing a cure for human HIV infection. Kamel Khalili, PhD, Laura H. Carnell Professor and Chair of the Department of Neuroscience, Director of the Center for Neurovirology and Director of the Comprehensive NeuroAIDS Center at LKSOM, is a senior co-investigator on the study along with Tricia H. Burdo, PhD, Associate Professor and Associate Chair of Education in the Department of Neuroscience at LKSOM, and colleagues at Tulane and the Texas Biomedical Research Institute. Pietro Mancuso, PhD, an Assistant Scientist in Dr. Khalili’s laboratory in the Department of Neuroscience at LKSOM, is the first author on the report, published online in the journal Nature Communications. Media outlets including Salon, Forbes, Yahoo! Finance, the Associated Press, Markets Insider and Morningstar, highlighted the breakthrough research.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH